Bredgade 6 3
1260 København K
1 January 2024 - 31 December 2024
| Reporting company | ||
| CVR-no.: | ||
| Reporting period: | ||
| Auditor | ||
| CVR-no.: | ||
| P-number: | ||
The Executive Board has today considered and adopted the Annual Report of Organon Denmark ApS for the financial year 1 January - 31 December 2024.
The Annual Report is prepared in accordance with the Danish Financial Statements Act.
In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2024 of the Company and of the results of the Company operations for 2024.
We recommend that the Annual Report be adopted at the Annual General Meeting.
|
|
|
|
CVR-no.: |
Key activities
The Company’s business is importing and selling pharmaceuticals to treat patients within Women’s health (reproductive health and contraceptives), Cardiovascular, Dermatology, Parkinson diseases and Migraine.
The Company, which is headquartered in Copenhagen, is a wholly owned subsidiary of OBS Human Health Holding B.V., Oss, Holland with registration number 75947293, which is part of the Group of which Organon & Co., Inc. 30 Hudson Street, Jersey City, NJ 07302, USA is the final parent company.
The Annual Report of Organon Denmark ApS for 2024 has been prepared in accordance with provision of the Danish Financial Statements Act applying to enterprises of reporting class B as well as selected rules applying to reporting class C.
The Financial Statements for 2024 are presented in TDKK.
Change in accounting policies
The method for recognition and measurement of “Other operating income” has been changed for 2024.
Previously, the amount included only the Mark Up Fee related to expenses recharged to Organon International, and the expenses which were recharged, were reduced in “Other external expenses” and “Staff expenses” expenses, respectively.
For 2024, “Other operating income” includes both the recharged expenses and the mark up fee.
The comparison amounts for 2023 have been updated accordingly.
The change has no impact on the result or equity.
Otherwise, the accounting policies applied remain unchanged from last year.
Recognition and measurement
Revenues are recognized in the income statement as earned. Furthermore, value adjustments of financial assets and liabilities measured at fair value or amortized cost are recognized. Moreover, all expenses incurred to achieve the earnings for the year are recognized in the income statement, including depreciation, amortization, impairment losses and provisions as well as reversals due to changed accounting estimates of amounts that have previously been recognized in the income statement.
Assets are recognized in the balance sheet when it is probable that future economic benefits attributable to the asset will flow to the Company, and the value of the asset can be measured reliably.
Liabilities are recognized in the balance sheet when it is probable that future economic benefits will flow out of the Company, and the value of the liability can be measured reliably.
Assets and liabilities are initially measured at cost. Subsequently, assets and liabilities are measured as described for each item below.
Translation policies
Transactions in foreign currencies are translated at the exchange rates at the dates of transaction.
Exchange differences arising due to differences between the transaction date rates and the rates at the dates of payment are recognized in financial income and expenses in the income statement.
Receivables, payables and other monetary items in foreign currencies that have not been settled at the balance sheet date are translated at the exchange rates at the balance sheet date. Any differences between the exchange rates at the balance sheet date and the rates at the time when the receivable or the debt arose are recognized in financial income and expenses in the income statement.
Income Statement
Revenue
Revenue from the sale of goods for resale and finished goods is recognized in the income statement when delivery and transfer of risk to the buyer have been made before year end.
Revenue is recognized exclusive of VAT and net of discounts relating to sales.
Other operating income
Other operating income comprise of expenses and mark-up on the Company's cluster expenses and research activities recharged to group companies.
Expenses for raw materials and consumables
Expenses for raw materials and consumables comprise the raw materials and consumables consumed to achieve revenue for the year.
Other external expenses
Other external expenses comprise indirect production costs and expenses for premises, sales and distribution as well as office expenses, etc.
Staff expenses
Staff expenses comprise of salaries, pension, employee benefits and social security expenses.
Amortization, depreciation and impairment losses
Amortization, depreciation and impairment losses comprise amortization, depreciation and impairment of property, plant and equipment.
Financial income and expenses
Financial income and expenses are recognized in the income statement at the amounts relating to the financial year.
Tax on profit/loss for the year
Tax for the year consists of current tax for the year and changes in deferred tax for the year. The tax attributable to the profit for the year is recognized in the income statement, whereas the tax attributable to equity transactions is recognized directly in equity.
Balance Sheet
Property, plant and equipment
Property, plant and equipment are measured at cost less accumulated depreciation and less any accumulated impairment losses.
Cost comprises the cost of acquisition and expenses directly related to the acquisition up until the time when the asset is ready for use.
Depreciation based on cost reduced by any residual value is calculated on a straight-line basis over the expected useful lives of the assets, which are:
Leasehold improvements: 3 years
Other fixtures & equipment: 5 years
Depreciation period and residual value are reassessed annually.
Impairment of fixed assets
The carrying amounts of intangible assets and property, plant and equipment are reviewed on an annual basis to determine whether there is any indication of impairment other than that expressed by amortization and depreciation.
If so, the asset is written down to its lower recoverable amount.
Fixed asset investments
Fixed asset investments consist of other receivables.
Receivables
Receivables are measured in the balance sheet at amortized cost, which substantially corresponds to nominal value. Provisions for estimated bad debts are made.
Prepayments
Prepayments comprise prepaid expenses concerning prepaid rent and subscriptions.
Provisions
Provisions are recognized when - in consequence of an event occurred before or on the balance sheet date - the Company has a legal or constructive obligation and it is probable that economic benefits must be given up to settle the obligation.
Deferred tax assets and liabilities
Deferred income tax is measured using the balance sheet liability method in respect of temporary differences arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes on the basis of the intended use of the asset and settlement of the liability, respectively.
Deferred tax assets are measured at the value at which the asset is expected to be realized, either by elimination in tax on future earnings or by set-off against deferred tax liabilities.
Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the legislation at the balance sheet date when the deferred tax is expected to crystallize as current tax. Any changes in deferred tax due to changes to tax rates are recognized in the income statement or in equity if the deferred tax relates to items recognized in equity.
Current tax receivables and liabilities
Current tax liabilities and receivables are recognized in the balance sheet as the expected taxable incomefor the year adjusted for tax on taxable income for prior years and tax paid on account. Extra paymentsand repayment under the on-account taxation scheme are recognized in the income statement in financialincome and expenses.
Financial debts
Debts are measured at amortized cost, substantially corresponding to nominal value.
| Disclosure | 2024 | 2023 | |
|---|---|---|---|
| DKK | DKK | ||
| Revenue |
|
|
|
| Cost of sales |
- |
- |
|
| Other operating income | 1 |
|
|
| External expenses |
- |
- |
|
| Gross Result |
|
|
|
| Wages and salaries |
- |
- |
|
| Post-employment benefit expense |
- |
- |
|
| Social security contributions |
- |
- |
|
| Depreciation, amortisation expense and impairment losses of property, plant and equipment and intangible assets |
- |
- |
|
| Profit (loss) from ordinary operating activities |
|
|
|
| Other finance income from group enterprises |
|
|
|
| Other finance income |
|
|
|
| Sundry finance expenses |
- |
- |
|
| Profit (loss) from ordinary activities before tax |
|
|
|
| Tax expense |
- |
- |
|
| Profit (loss) |
|
|
|
| Proposed distribution of results | |||
| Proposed dividend recognised in equity |
|
|
|
| Retained earnings |
|
|
|
| Proposed distribution of profit (loss) |
|
|
| Disclosure | 2024 | 2023 | |
|---|---|---|---|
| DKK | DKK | ||
| Leasehold improvements |
|
|
|
| Right of use assets |
|
|
|
| Property, plant and equipment in progress |
|
||
| Property, plant and equipment |
|
|
|
| Other receivables |
|
|
|
| Investments |
|
|
|
| Total non-current assets |
|
|
|
| Trade receivables |
|
|
|
| Receivables from group enterprises |
|
|
|
| Current deferred tax assets |
|
|
|
| Other receivables |
|
|
|
| Deferred income assets |
|
|
|
| Receivables |
|
|
|
| Cash and cash equivalents |
|
|
|
| Current assets |
|
|
|
| Total assets |
|
|
| Disclosure | 2024 | 2023 | |
|---|---|---|---|
| DKK | DKK | ||
| Paid contributed capital |
|
|
|
| Retained earnings |
|
|
|
| Proposed dividend |
|
|
|
| Total equity |
|
|
|
| Other provisions |
|
|
|
| Provisions, gross |
|
|
|
| Trade payables |
|
|
|
| Payables to group enterprises |
|
|
|
| Tax payables |
|
|
|
| Other payables, including tax payables, liabilities other than provisions |
|
|
|
| Short-term liabilities other than provisions, gross |
|
|
|
| Liabilities other than provisions, gross |
|
|
|
| Liabilities and equity, gross |
|
|
| 2024 | 2023 | |
|---|---|---|
| kr. | kr. | |
| Expenses recharged to affiliated companies | 13033000 | 13621000 |
| Mark up fees | 587000 | 669000 |
| 13620000 | 14290000 | |
| 2024 | |||
|---|---|---|---|
| Average number of employees |
|